# clm_CE8800B79AA0

subject: Amgen (/record/amgen.md)  
predicate: quarterly_revenue  
value: 8,388,000,000 United States dollar  
valid_from: 2024-06-30  
valid_to: 2024-09-30  
published: 2024-08-07  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_BF9D0F8819AD  
last_updated: 2026-11-08  
cite: AsOf. "Amgen quarterly revenue: 8,388,000,000 United States dollar", as of 2024-06-30 (until 2024-09-30). Claim clm_CE8800B79AA0, https://asof.is/claim/clm_CE8800B79AA0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815424000035/0000318154-24-000035-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2024, filed 2024-08-07  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815424000035/0000318154-24-000035-index.htm (primary, SEC EDGAR 10-Q Q2 FY2024, published 2024-08-07)

## Supersedes

- [Amgen](/record/amgen.md) | quarterly_revenue | 7,447,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_CE8800B79AA0](/claim/clm_CE8800B79AA0.md) | [clm_458A0C01DCF8](/claim/clm_458A0C01DCF8.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.